C26H21ClFN9O — CID 46191039
3-[(3R)-7-chloro-3-[3-(4-fluorophenyl)-1H-1,2,4-triazol-5-yl]-1-(1-methylpyrazol-4-yl)-2,3,4,9-tetrahydropyrido[3,4-b]indol-1-yl]-5-methyl-1,2,4-oxadiazole (PubChem CID 46191039) has the molecular formula C26H21ClFN9O and a molecular weight of 529.97 g/mol. Its IUPAC name is 3-[(3R)-7-chloro-3-[3-(4-fluorophenyl)-1H-1,2,4-triazol-5-yl]-1-(1-methylpyrazol-4-yl)-2,3,4,9-tetrahydropyrido[3,4-b]indol-1-yl]-5-methyl-1,2,4-oxadiazole.
| Compound Name | 3-[(3R)-7-chloro-3-[3-(4-fluorophenyl)-1H-1,2,4-triazol-5-yl]-1-(1-methylpyrazol-4-yl)-2,3,4,9-tetrahydropyrido[3,4-b]indol-1-yl]-5-methyl-1,2,4-oxadiazole |
|---|---|
| PubChem CID | 46191039 |
| Molecular Formula | C26H21ClFN9O |
| Molecular Weight | 529.97 g/mol |
| Exact Mass | 529.15 |
| IUPAC Name | 3-[(3R)-7-chloro-3-[3-(4-fluorophenyl)-1H-1,2,4-triazol-5-yl]-1-(1-methylpyrazol-4-yl)-2,3,4,9-tetrahydropyrido[3,4-b]indol-1-yl]-5-methyl-1,2,4-oxadiazole |
| SMILES | Cc1nc(C2(c3cnn(C)c3)N[C@@H](c3nc(-c4ccc(F)cc4)n[nH]3)Cc3c2[nH]c2cc(Cl)ccc32)no1 |
| InChI | InChI=1S/C26H21ClFN9O/c1-13-30-25(36-38-13)26(15-11-29-37(2)12-15)22-19(18-8-5-16(27)9-20(18)31-22)10-21(33-26)24-32-23(34-35-24)14-3-6-17(28)7-4-14/h3-9,11-12,21,31,33H,10H2,1-2H3,(H,32,34,35)/t21-,26?/m1/s1 |
| InChIKey | KTZHKXDQMJAPFM-OSMGYRLQSA-N |
| XLogP | 4.35 |
| TPSA | 126.13 Ų |
| H-Bond Donors | 3 |
| H-Bond Acceptors | 8 |
| Rotatable Bonds | 4 |
| Heavy Atoms | 38 |
| Complexity | — |
1 violation
| Rule | Value |
|---|---|
| MW ≤ 500 | 529.97 |
| LogP ≤ 5 | 4.35 |
| H-Bond Donors ≤ 5 | 3 |
| H-Bond Acceptors ≤ 10 | 8 |